A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides

Daniel Albert, Ronald E. Gangnon, Hans E. Grossniklaus, W. Richard Green, Soesiawati Darjatmoko, Amol D. Kulkarni

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objectives: To study the histopathological features of latanoprost-treated irides with or without darkening, compared with non-latanoprost-treated irides. Methods: Iridectomy specimens and patient history forms were independently examined by 3 ophthalmic pathologists in a masked fashion. Specimens were evaluated for premalignant changes and for differences in level of pigmentation and degrees of cellularity, inflammation, and vascular abnormalities. Results: The specimens consisted of 22 latanoprost-treated darkened irides, 35 latanoprost-treated irides without darkening, and 35 non-latanoprost-treated irides. There was a statistically significant decrease in the number of nuclear invaginations and prominent nucleoli in latanoprost-treated darkened irides compared with the other 2 groups (P = .004 and P = .005, respectively). The average thickness and pigmentation of the anterior border layer was greater in the latanoprost-treated darkened irides than in the other 2 groups (P = .03 and P = .02, respectively). The latanoprost-treated darkened irides had increased pigmentation of the stroma (P < .001), stromal fibroblasts (P < .001), melanocytes (P = .005), vascular endothelium (P = .02), and adventitia (P < .001) relative to the other 2 groups. Conclusions: There is no histopathological evidence of premalignant changes in latanoprost-treated darkened irides. The latanoprost-induced iris color changes are due to a thickening of the anterior border layer and an increased amount of melanin in the anterior border layer and within the stromal melanocytes.

Original languageEnglish (US)
Pages (from-to)626-631
Number of pages6
JournalArchives of ophthalmology
Volume126
Issue number5
DOIs
StatePublished - May 1 2008
Externally publishedYes

Fingerprint

latanoprost
Iris
Pigmentation
Melanocytes
Iridectomy
Adventitia

ASJC Scopus subject areas

  • Ophthalmology

Cite this

A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides. / Albert, Daniel; Gangnon, Ronald E.; Grossniklaus, Hans E.; Green, W. Richard; Darjatmoko, Soesiawati; Kulkarni, Amol D.

In: Archives of ophthalmology, Vol. 126, No. 5, 01.05.2008, p. 626-631.

Research output: Contribution to journalArticle

Albert, Daniel ; Gangnon, Ronald E. ; Grossniklaus, Hans E. ; Green, W. Richard ; Darjatmoko, Soesiawati ; Kulkarni, Amol D. / A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides. In: Archives of ophthalmology. 2008 ; Vol. 126, No. 5. pp. 626-631.
@article{05d214c06ffd41aaab04e3313b4dfe2a,
title = "A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides",
abstract = "Objectives: To study the histopathological features of latanoprost-treated irides with or without darkening, compared with non-latanoprost-treated irides. Methods: Iridectomy specimens and patient history forms were independently examined by 3 ophthalmic pathologists in a masked fashion. Specimens were evaluated for premalignant changes and for differences in level of pigmentation and degrees of cellularity, inflammation, and vascular abnormalities. Results: The specimens consisted of 22 latanoprost-treated darkened irides, 35 latanoprost-treated irides without darkening, and 35 non-latanoprost-treated irides. There was a statistically significant decrease in the number of nuclear invaginations and prominent nucleoli in latanoprost-treated darkened irides compared with the other 2 groups (P = .004 and P = .005, respectively). The average thickness and pigmentation of the anterior border layer was greater in the latanoprost-treated darkened irides than in the other 2 groups (P = .03 and P = .02, respectively). The latanoprost-treated darkened irides had increased pigmentation of the stroma (P < .001), stromal fibroblasts (P < .001), melanocytes (P = .005), vascular endothelium (P = .02), and adventitia (P < .001) relative to the other 2 groups. Conclusions: There is no histopathological evidence of premalignant changes in latanoprost-treated darkened irides. The latanoprost-induced iris color changes are due to a thickening of the anterior border layer and an increased amount of melanin in the anterior border layer and within the stromal melanocytes.",
author = "Daniel Albert and Gangnon, {Ronald E.} and Grossniklaus, {Hans E.} and Green, {W. Richard} and Soesiawati Darjatmoko and Kulkarni, {Amol D.}",
year = "2008",
month = "5",
day = "1",
doi = "10.1001/archopht.126.5.626",
language = "English (US)",
volume = "126",
pages = "626--631",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides

AU - Albert, Daniel

AU - Gangnon, Ronald E.

AU - Grossniklaus, Hans E.

AU - Green, W. Richard

AU - Darjatmoko, Soesiawati

AU - Kulkarni, Amol D.

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Objectives: To study the histopathological features of latanoprost-treated irides with or without darkening, compared with non-latanoprost-treated irides. Methods: Iridectomy specimens and patient history forms were independently examined by 3 ophthalmic pathologists in a masked fashion. Specimens were evaluated for premalignant changes and for differences in level of pigmentation and degrees of cellularity, inflammation, and vascular abnormalities. Results: The specimens consisted of 22 latanoprost-treated darkened irides, 35 latanoprost-treated irides without darkening, and 35 non-latanoprost-treated irides. There was a statistically significant decrease in the number of nuclear invaginations and prominent nucleoli in latanoprost-treated darkened irides compared with the other 2 groups (P = .004 and P = .005, respectively). The average thickness and pigmentation of the anterior border layer was greater in the latanoprost-treated darkened irides than in the other 2 groups (P = .03 and P = .02, respectively). The latanoprost-treated darkened irides had increased pigmentation of the stroma (P < .001), stromal fibroblasts (P < .001), melanocytes (P = .005), vascular endothelium (P = .02), and adventitia (P < .001) relative to the other 2 groups. Conclusions: There is no histopathological evidence of premalignant changes in latanoprost-treated darkened irides. The latanoprost-induced iris color changes are due to a thickening of the anterior border layer and an increased amount of melanin in the anterior border layer and within the stromal melanocytes.

AB - Objectives: To study the histopathological features of latanoprost-treated irides with or without darkening, compared with non-latanoprost-treated irides. Methods: Iridectomy specimens and patient history forms were independently examined by 3 ophthalmic pathologists in a masked fashion. Specimens were evaluated for premalignant changes and for differences in level of pigmentation and degrees of cellularity, inflammation, and vascular abnormalities. Results: The specimens consisted of 22 latanoprost-treated darkened irides, 35 latanoprost-treated irides without darkening, and 35 non-latanoprost-treated irides. There was a statistically significant decrease in the number of nuclear invaginations and prominent nucleoli in latanoprost-treated darkened irides compared with the other 2 groups (P = .004 and P = .005, respectively). The average thickness and pigmentation of the anterior border layer was greater in the latanoprost-treated darkened irides than in the other 2 groups (P = .03 and P = .02, respectively). The latanoprost-treated darkened irides had increased pigmentation of the stroma (P < .001), stromal fibroblasts (P < .001), melanocytes (P = .005), vascular endothelium (P = .02), and adventitia (P < .001) relative to the other 2 groups. Conclusions: There is no histopathological evidence of premalignant changes in latanoprost-treated darkened irides. The latanoprost-induced iris color changes are due to a thickening of the anterior border layer and an increased amount of melanin in the anterior border layer and within the stromal melanocytes.

UR - http://www.scopus.com/inward/record.url?scp=43549086687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43549086687&partnerID=8YFLogxK

U2 - 10.1001/archopht.126.5.626

DO - 10.1001/archopht.126.5.626

M3 - Article

VL - 126

SP - 626

EP - 631

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 5

ER -